LifeScience Biotech
Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...
January 03, 2022 | News
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it...
December 23, 2021 | News
Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG...
December 23, 2021 | News
Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Cladrib...
December 22, 2021 | News
Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation and funding by Novar...
December 22, 2021 | News
he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...
December 20, 2021 | News
Compatible equipment and consumables will allow for quick and streamlined validation of freeze-thaw solutions for customers along with easier purchase an...
December 16, 2021 | News
Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunolo...
December 16, 2021 | News
After successfully isolating the SARS-CoV-2 Omicron variant from clinical specimens, researchers at the Department of Microbiology at The University of Hon...
December 14, 2021 | News
We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executiv...
December 09, 2021 | News
Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders Funds raised will und...
December 09, 2021 | News
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceut...
December 07, 2021 | News
Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE™ antiviral nasal spray in&nb...
December 06, 2021 | News
BC-PIV, an innovative non-transmissible viral vector co-developed by BioComo and Mie University, is derived from the recombinant human parainfluenza virus ...
December 03, 2021 | News
Most Read
Bio Jobs
News
Editor Picks